How Does Breztri Aerosphere Work? Mechanism of Action Explained in Plain English

Breztri Aerosphere is a triple-combination inhaler that contains three different medications — budesonide, glycopyrrolate, and formoterol fumarate. Each one targets a different aspect of the airway problems that cause COPD and asthma symptoms. Understanding how Breztri works helps you understand why triple therapy is more effective than single or dual medications, and why consistent daily use matters. Let's break it down simply.

The Problem: What Goes Wrong in COPD and Asthma Airways?

Whether you have COPD or asthma, the core problem is airways that are too narrow, making it hard for air to flow in and out of your lungs. This narrowing happens in three main ways:

Inflammation: The airway lining becomes swollen, red, and irritated. This thickens the airway walls and triggers mucus production. In COPD, this is often driven by years of smoke or pollutant exposure. In asthma, it's often triggered by allergens or other irritants.

Smooth muscle contraction (bronchoconstriction): Muscles wrapped around the airways squeeze them tighter, narrowing the passage further. This can be triggered by signals from the nervous system (specifically acetylcholine acting on muscarinic receptors) or by irritants and allergens (which stimulate different receptors).

Airway remodeling (in COPD): In COPD, long-term damage causes permanent structural changes to the airways and air sacs (alveoli). This is the irreversible component that maintenance therapy aims to slow.

How Budesonide Works: Fighting Inflammation

Budesonide is an inhaled corticosteroid (ICS). When you inhale it, it travels deep into your airways and enters the cells lining the airway walls. Inside the cell, it binds to glucocorticoid receptors — proteins that act as master switches for gene expression. This binding triggers a cascade that:

Reduces production of inflammatory chemicals (cytokines, leukotrienes, prostaglandins)

Suppresses the activity of immune cells (mast cells, eosinophils, macrophages) that drive airway inflammation

Decreases mucus production and airway wall swelling

Because it's inhaled rather than taken as a pill, most of the budesonide stays in the lungs rather than circulating through the bloodstream. This gives it a powerful local anti-inflammatory effect with fewer whole-body side effects than oral steroids. However, some systemic absorption does occur, which is why long-term users are monitored for effects like decreased bone mineral density.

How Glycopyrrolate Works: Relaxing the Airways via the Nervous System

Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) — a type of anticholinergic drug. To understand how it works, you need to know a little about the nervous system's role in airway control.

The parasympathetic nervous system releases a chemical messenger called acetylcholine. In the airways, acetylcholine binds to receptors called muscarinic receptors on the smooth muscle cells wrapped around your airways. This causes those muscles to contract — tightening the airways and making it harder to breathe. In COPD, this nervous system signaling is often overactive.

Glycopyrrolate blocks these muscarinic receptors. With the receptors blocked, acetylcholine can't bind and trigger muscle contraction. The smooth muscle relaxes, the airways open up, and airflow improves. The effect begins within minutes of inhalation (peak within 2–6 minutes) and lasts up to 12 hours, which is why Breztri is dosed twice daily.

How Formoterol Works: A Second Pathway to Open Airways

Formoterol fumarate is a long-acting beta2-adrenergic agonist (LABA). It works through a completely different pathway than glycopyrrolate:

Formoterol binds to beta2-adrenergic receptors on airway smooth muscle cells — the same type of receptors that adrenaline (epinephrine) stimulates during a "fight or flight" response. When activated, these receptors trigger an increase in a molecule called cyclic AMP (cAMP) inside the cell. Elevated cAMP causes the smooth muscle to relax, widening the airway and improving airflow.

What makes formoterol particularly useful is that it has a rapid onset (lung function improvement detectable within 5 minutes) combined with long duration (up to 12 hours). This combination profile — fast-acting but long-lasting — makes it effective for preventing symptoms while also providing some early relief.

Why Triple Therapy Works Better Than Dual Therapy

COPD and asthma involve multiple overlapping disease mechanisms simultaneously. Using only one or two drug classes leaves one or more pathways untreated. Triple therapy with an ICS + LAMA + LABA addresses all three major pathways at once:

ICS (budesonide): Dampens the inflammatory response that causes swelling and mucus overproduction

LAMA (glycopyrrolate): Blocks the nervous system signals that tighten airways via acetylcholine-muscarinic receptor pathway

LABA (formoterol): Directly relaxes airway smooth muscle via beta2-adrenergic receptor activation

The ETHOS clinical trial demonstrated that this combined approach reduces moderate-to-severe COPD exacerbations by 24% compared to LAMA/LABA alone and 13% compared to ICS/LABA alone. The three drugs are synergistic — together they work better than any combination of two.

Why Does Breztri Need to Be Taken Twice Daily?

Each component of Breztri has a duration of action of approximately 12 hours at standard doses. This means twice-daily dosing (morning and evening) provides consistent 24-hour coverage with no gaps. Unlike once-daily inhalers like Trelegy Ellipta, Breztri must be taken at roughly 12-hour intervals to maintain effective drug levels throughout the day.

For a complete overview of Breztri's uses, dosage, and what to expect, see our guide: What Is Breztri Aerosphere?.

Having trouble finding Breztri at your pharmacy? medfinder calls pharmacies near you and texts you which ones have it in stock.